Sign In
Pharma
Dr Reddy’s, FDC Recall Products In US Over Mfg Issues
National
Nestle India Transfers Medical Nutrition Business to Dr Reddy’s JV for ₹218.9 Crore
Telangana State
Dr Reddy’s biosimilar cancer drug closer to gets EU nod
Dr Reddy's Q1 net profit at Rs 1,392 cr
Dr Reddy's posts 1 pc drop in net profit at Rs 1,392 crore in Q1, revenue up 14 pc
Dr Reddy’s to sell Vonoprazan tablets in India
Dr Reddy’s, Sun Pharma recall drugs in US mkt
Dr Reddy’s acquires Haleon’s Global NRT biz for $633 mn
Dr Reddy’s expands biosimilar portfolio with Alvotech tie up
3 pharma majors recall products in US
Dr Reddy’s net rises 36% in Q4
Dr Reddy’s Laboratories clocks 36 pc surge in Q4 net profit
